Plain-English translation of NCT07117162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new way to deliver care for veterans with early memory loss or mild dementia. Instead of the usual approach, this protocol uses telehealth visits and blood tests done before you see a memory specialist, which may help doctors diagnose your condition and determine if you're eligible for newer amyloid-targeting therapies more quickly.
Many veterans with early memory loss have to wait a long time to see specialists and get the right tests done. This trial exists to see whether using telehealth and blood biomarkers upfront can speed up the process so patients can access treatment sooner.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the new care protocol, you will have a telehealth preparation appointment, a memory screening test, and blood work done before meeting with a memory specialist—all designed to get you faster answers. If you are in the usual care group, you will receive standard evaluation and testing as your specialist decides. The study involves 30 veterans total at VA Pittsburgh.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States
Sponsor
VA Pittsburgh Healthcare System
Enrollment target
~30 participants
Started
October 2025
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alison O'Donnell, DO, MPH
VA Pittsburgh Healthcare System
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.